Inomed

Inosine Pranobex, the active ingredient in Inomed, is an immunomodulator presented as an oral dosage form for systemic use. It is employed to manage viral infections and to support immune function in patients with compromised immunity.

GNH USA supplies Inomed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Inomed is an immunomodulatory antiviral indicated for several viral and immune‑related conditions. - Herpes simplex virus infections: reduces lesion duration and severity. - Influenza and other acute viral respiratory infections: shortens illness course and alleviates symptoms. - Subacute sclerosing panencephalitis (SSPE): provides antiviral activity that may slow disease progression. - Support of immune function in immunodeficient patients: enhances cellular immunity and interferon production.

Adverse reactions may occur with Inomed and are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Dizziness: occasional light‑headedness. - Rash: mild skin erythema. - Elevated liver enzymes: reversible laboratory changes.

Serious or Rare Side Effects: - Severe hypersensitivity: anaphylaxis or angioedema. - Hematologic abnormalities: leukopenia or thrombocytopenia. - Hepatotoxicity: significant liver injury. - Cardiac arrhythmias: rare conduction disturbances. - Autoimmune reactions: exacerbation of autoimmune disease.

Before initiating therapy, consider the following safety measures. - Pregnancy: use only if potential benefit outweighs risk; data are limited. - Breastfeeding: assess risk to infant; drug may be excreted in milk. - Liver impairment: monitor hepatic function and adjust use if needed. - Renal impairment: evaluate renal function; dose adjustment may be required. - Concomitant immunosuppressants: increased infection risk; monitor closely. - Store at below 25°C: keep in original packaging, protect from moisture and direct sunlight.

Inomed may interact with other medicines; awareness of interaction severity helps guide monitoring.

Major Interactions (Avoid): - Immunosuppressive agents: may blunt antiviral efficacy. - Live vaccines: increased risk of vaccine‑derived infection.

Moderate Interactions (Monitor Closely): - Hepatotoxic drugs (e.g., azole antifungals): may elevate liver enzyme levels. - Anticoagulants (e.g., warfarin): potential alteration of coagulation parameters. - CNS depressants: additive dizziness or sedation. - Antiretroviral therapy: possible pharmacodynamic interference. - Herbal supplements (e.g., St. John’s wort): may affect drug metabolism.